{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:35:32Z","timestamp":1779377732708,"version":"3.53.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41440-021-00685-3","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T06:16:55Z","timestamp":1630304215000},"page":"1428-1433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Chinese pedigree with glucocorticoid remediable aldosteronism"],"prefix":"10.1038","volume":"44","author":[{"given":"Xiaoning","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"685_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/sj.jhh.1001821","volume":"19","author":"F Pizzolo","year":"2005","unstructured":"Pizzolo F, Trabetti E, Guarini P, Mulatero P, Ciacciarelli A, Blengio GS, et al. Glucocorticoid remediable aldosteronism (GRA) screening in hypertensive patients from a primary care setting. J Hum Hypertens. 2005;19:325\u2013327.","journal-title":"J Hum Hypertens"},{"key":"685_CR2","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J. 1966;95:1109\u20131119.","journal-title":"Can Med Assoc J"},{"key":"685_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","volume":"31","author":"WR Litchfield","year":"1998","unstructured":"Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 1998;31:445\u2013450. 1 Pt 2","journal-title":"Hypertension"},{"key":"685_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ng0992-66","volume":"2","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet. 1992;2:66\u201374.","journal-title":"Nat Genet"},{"key":"685_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","volume":"207","author":"JR Jonsson","year":"1995","unstructured":"Jonsson JR, Klemm SA, Tunny TJ, Stowasser M, Gordon RD. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Commun. 1995;207:565\u2013571.","journal-title":"Biochem Biophys Res Commun"},{"key":"685_CR6","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1210\/jcem.83.12.5309","volume":"83","author":"AA MacConnachie","year":"1998","unstructured":"MacConnachie AA, Kelly KF, McNamara A, Loughlin S, Gates LJ, Inglis GC, et al. Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism. J Clin Endocrinol Metab. 1998;83:4328\u20134331.","journal-title":"J Clin Endocrinol Metab"},{"key":"685_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/BF03347044","volume":"34","author":"CA Carvajal","year":"2011","unstructured":"Carvajal CA, Stehr CB, Gonz\u00e1lez PA, Riquelme EM, Montero T, Santos MJ, et al. A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I. J Endocrinol Investig. 2011;34:140\u2013144.","journal-title":"J Endocrinol Investig"},{"key":"685_CR8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ng.213","volume":"40","author":"S Myers","year":"2008","unstructured":"Myers S, Freeman C, Auton A, Donnelly P, McVean G. A common sequence motif associated with recombination hot spots and genome instability in humans. Nat Genet. 2008;40:1124\u20131129.","journal-title":"Nat Genet"},{"key":"685_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0337-9","volume":"51","author":"E Seidel","year":"2019","unstructured":"Seidel E, Schewe J, Scholl UI. Genetic causes of primary aldosteronism. Exp Mol Med. 2019;51:1\u201312.","journal-title":"Exp Mol Med"},{"key":"685_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1067\/mpd.2001.112648","volume":"138","author":"RG Dluhy","year":"2001","unstructured":"Dluhy RG, Anderson B, Harlin B, Ingelfinger J, Lifton R. Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood. J Pediatr. 2001;138:715\u2013720.","journal-title":"J Pediatr"},{"key":"685_CR11","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1210\/jcem.87.7.8647","volume":"87","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, di Cella SM, Williams TA, Milan A, Mengozzi G, Chiandussi L, et al. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. J Clin Endocrinol Metab. 2002;87:3187\u20133191.","journal-title":"J Clin Endocrinol Metab"},{"key":"685_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0039-128X(94)00010-A","volume":"60","author":"RG Dluhy","year":"1995","unstructured":"Dluhy RG, Lifton RP. Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids. 1995;60:48\u201351.","journal-title":"Steroids"},{"key":"685_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1042\/cs0880563","volume":"88","author":"A Jamieson","year":"1995","unstructured":"Jamieson A, Slutsker L, Inglis GC, Fraser R, White PC, Connell JM. Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression. Clin Sci. 1995;88:563\u2013570.","journal-title":"Clin Sci"},{"key":"685_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","volume":"116","author":"GM Rich","year":"1992","unstructured":"Rich GM, Ulick S, Cook S, Wang JZ, Lifton RP, Dluhy RG. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med. 1992;116:813\u2013820.","journal-title":"Ann Intern Med"},{"key":"685_CR15","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","volume":"83","author":"P Mulatero","year":"1998","unstructured":"Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, et al. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab. 1998;83:2573\u20132575.","journal-title":"J Clin Endocrinol Metab"},{"key":"685_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/01.crd.0000096417.42861.ce","volume":"12","author":"GT McMahon","year":"2004","unstructured":"McMahon GT, Dluhy RG. Glucocorticoid-remediable aldosteronism. Cardiol Rev. 2004;12:44\u201348.","journal-title":"Cardiol Rev"},{"key":"685_CR17","first-page":"3570","volume":"82","author":"WR Litchfield","year":"1997","unstructured":"Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab. 1997;82:3570\u20133573.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00685-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00685-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00685-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:04:15Z","timestamp":1636070655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00685-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1038\/s41440-021-00685-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"assertion":[{"value":"11 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}